相关实验视频

Updated: Jun 22, 2025

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

8.0K

[乳腺癌的临床病理特征与HER2低表达:一个现实世界的回顾性研究]

K M Li1, S F Wu1, M C Sun1

  • 1Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.

Zhonghua bing li xue za zhi = Chinese journal of pathology
|July 2, 2024
PubMed
概括

低HER2的乳腺癌,以特定的免疫组织化学 (IHC) 评分为特征,与HER2 IHC 0瘤相比,具有明显的临床和病理特征. 需要进一步的研究来确定HER2-low是否是一种独特的生物实体.

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells08:29

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

96

相关概念视频